Bionomics Limited (BNOX)
USD 0.26
(-4.03%)
USD 0.26
(-4.03%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 239.61 Million USD | -23.21% |
| 2023 | 355.17 Thousand USD | -25.53% |
| 2022 | 476.96 Thousand USD | -26.79% |
| 2021 | 651.53 Thousand USD | -92.27% |
| 2020 | 8.42 Million USD | -34.39% |
| 2019 | 12.84 Million USD | -18.91% |
| 2018 | 15.83 Million USD | 11.54% |
| 2017 | 14.19 Million USD | -9.92% |
| 2016 | 15.76 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 103.59 Thousand USD | 0.0% |
| 2024 Q1 | 896.66 Thousand USD | 152.45% |
| 2024 Q2 | 1.07 Million USD | 19.59% |
| 2023 Q3 | 241.83 Thousand USD | -41.97% |
| 2023 FY | 355.17 Thousand USD | -25.53% |
| 2023 Q4 | 355.17 Thousand USD | 46.87% |
| 2023 Q2 | 416.75 Thousand USD | 45.22% |
| 2023 Q1 | 286.97 Thousand USD | -39.83% |
| 2022 Q4 | 476.96 Thousand USD | 0.0% |
| 2022 FY | 476.96 Thousand USD | -26.79% |
| 2022 Q2 | 559.05 Thousand USD | 0.0% |
| 2021 Q4 | 651.53 Thousand USD | 0.0% |
| 2021 Q2 | 7.48 Million USD | 0.0% |
| 2021 FY | 651.53 Thousand USD | -92.27% |
| 2020 Q4 | 8.42 Million USD | 0.0% |
| 2020 FY | 8.42 Million USD | -34.39% |
| 2020 Q2 | 9.67 Million USD | 0.0% |
| 2019 Q4 | 11.99 Million USD | 0.0% |
| 2019 FY | 12.84 Million USD | -18.91% |
| 2018 FY | 15.83 Million USD | 11.54% |
| 2017 FY | 14.19 Million USD | -9.92% |
| 2016 FY | 15.76 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -4.44% |
| IO Biotech, Inc. | 2.49 Million USD | -9507.779% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -111871.028% |
| Organovo Holdings, Inc. | 1.39 Million USD | -17089.24% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -490217.168% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -146037.942% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -2341.842% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -3311.418% |
| Savara Inc. | 26.73 Million USD | -796.17% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -35398.963% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -856.864% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1047.363% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -2768130.129% |
| Soligenix, Inc. | 3.49 Million USD | -6756.884% |
| Aptose Biosciences Inc. | 1 Million USD | -23629.112% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1102.841% |
| Century Therapeutics, Inc. | 48.17 Million USD | -397.432% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -472.66% |
| Precision BioSciences, Inc. | 31.26 Million USD | -666.336% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -28.57% |
| Kura Oncology, Inc. | 17.2 Million USD | -1293.128% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Dyadic International, Inc. | 136.92 Thousand USD | -174894.34% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -159.234% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -8243.245% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1614.742% |
| Autolus Therapeutics plc | 52.96 Million USD | -352.391% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -4292.631% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -4281.386% |
| GRI Bio, Inc. | 14 Thousand USD | -1711457.143% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1828.67% |
| IGM Biosciences, Inc. | 40.5 Million USD | -491.562% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -33.397% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3956.469% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -28879.832% |
| Opthea Limited | 200.62 Million USD | -19.434% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -311.143% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -314.048% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -2007.088% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -3786.748% |
| Surrozen, Inc. | 3.37 Million USD | -6991.388% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 3.13 Million USD | -7543.076% |
| Ovid Therapeutics Inc. | 46 Million USD | -420.889% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -78.149% |
| Acelyrin, Inc. | 1.19 Million USD | -19968.509% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -183.277% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -114538.791% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -693.017% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -286.014% |
| ADMA Biologics, Inc. | 141.41 Million USD | -69.44% |
| PureTech Health plc | 25.51 Million USD | -839.236% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -75251.572% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -13615.97% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1746.625% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -182.989% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -96911.336% |
| ChromaDex Corporation | 3.27 Million USD | -7212.115% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -38423.608% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -26.152% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -129.999% |
| Better Therapeutics, Inc. | 14.88 Million USD | -1510.336% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -682.707% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -116.012% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -528.853% |
| Seer, Inc. | 28.25 Million USD | -747.935% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -3808.94% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -3695.628% |
| Gritstone bio, Inc. | 104.77 Million USD | -128.698% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -8500.79% |
| Avid Bioservices, Inc. | 207.83 Million USD | -15.293% |
| Insmed Incorporated | 1.2 Billion USD | 80.098% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -4513.362% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -6039.329% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -131.434% |
| MediWound Ltd. | 6.71 Million USD | -3470.526% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -136.347% |
| Fortress Biotech, Inc. | 88.59 Million USD | -170.474% |
| OmniAb, Inc. | 25.56 Million USD | -837.436% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -12.005% |
| Zai Lab Limited | 15.15 Million USD | -1481.533% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 49.916% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -655.13% |
| Veracyte, Inc. | 12.63 Million USD | -1797.213% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -4337.37% |
| FibroGen, Inc. | 170.45 Million USD | -40.576% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -11680.635% |
| ContextLogic Inc. | 6 Million USD | -3893.633% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -151556.962% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -3553.27% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 95.866% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -251.192% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -647516.216% |
| ImmuCell Corporation | 11.96 Million USD | -1901.938% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 85.72% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -3174.812% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -8500.79% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -431.622% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -455.07% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -429.706% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -396.834% |
| Vaxxinity, Inc. | 15.16 Million USD | -1479.76% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 71.767% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -23222.802% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1688064.013% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1028.198% |
| Senti Biosciences, Inc. | 37.66 Million USD | -536.165% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -147523.478% |
| Apollomics, Inc. | 4.66 Million USD | -5040.914% |
| 89bio, Inc. | 27.1 Million USD | -783.938% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -108.054% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -53080.964% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -3369.708% |
| Ardelyx, Inc. | 55.98 Million USD | -328.027% |
| Pluri Inc. | 29.61 Million USD | -709.192% |
| Prothena Corporation plc | 11.83 Million USD | -1924.656% |
| Pulmatrix, Inc. | 8.75 Million USD | -2636.615% |
| Celularity Inc. | 65.41 Million USD | -266.293% |
| MeiraGTx Holdings plc | 89.26 Million USD | -168.437% |
| Omeros Corporation | 338.28 Million USD | 29.166% |
| Ainos, Inc. | 5.96 Million USD | -3918.039% |
| Humacyte, Inc. | 58.1 Million USD | -312.381% |
| Mesoblast Limited | 118.92 Million USD | -101.49% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -12831.355% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -4813.225% |
| Blueprint Medicines Corporation | 774.12 Million USD | 69.046% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -4675.169% |
| Summit Therapeutics Inc. | 106.09 Million USD | -125.844% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -287.618% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -107.738% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -659.535% |
| Cytokinetics, Incorporated | 755.77 Million USD | 68.295% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -1690.332% |
| Nutriband Inc. | 241.28 Thousand USD | -99209.116% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -4282.989% |
| Roivant Sciences Ltd. | 499.74 Million USD | 52.052% |
| Evogene Ltd. | 1.13 Million USD | -20956.063% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -19444.698% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -434265.993% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 86.228% |
| BioLineRx Ltd. | 11.59 Million USD | -1967.276% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1354.346% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -11202.736% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -145.493% |
| MediciNova, Inc. | 215.92 Thousand USD | -110872.278% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -9503.928% |
| MiMedx Group, Inc. | 48.09 Million USD | -398.177% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 42.264% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -6574.596% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -14555.535% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -293261.9% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2515.631% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1533.277% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -774.04% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1854.789% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1816.024% |
| Allakos Inc. | 41.46 Million USD | -477.88% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -2114.379% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -158587.417% |
| BioAtla, Inc. | 2.46 Million USD | -9640.569% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -151.909% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -4220.555% |
| Precigen, Inc. | 7.09 Million USD | -3276.328% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| XOMA Corporation | 124.45 Million USD | -92.542% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1165.61% |
| Incyte Corporation | 38.28 Million USD | -525.847% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -455.095% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -2051.356% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -0.413% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -820.086% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -68558.453% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -73291.466% |
| UroGen Pharma Ltd. | 100.21 Million USD | -139.106% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -31.119% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -69085.372% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -78463.279% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -3405.75% |
| Chimerix, Inc. | 2.14 Million USD | -11076.213% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -573.931% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -138669.813% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -803.776% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 47 Thousand USD | -509725.532% |
| OncoCyte Corporation | 2.86 Million USD | -8251.969% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -18343.277% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1122232.553% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -159057.512% |
| Purple Biotech Ltd. | 351 Thousand USD | -68167.236% |
| NextCure, Inc. | 6.6 Million USD | -3527.827% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -144.773% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -4480.73% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -4.549% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -24653.926% |
| NLS Pharmaceutics AG | 1.63 Million USD | -14566.784% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | 14.616% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 2.79 Million USD | -8476.163% |
| Daré Bioscience, Inc. | 5.31 Million USD | -4405.669% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -42310.265% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -433.006% |
| BeiGene, Ltd. | 930.18 Million USD | 74.24% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -1441.695% |
| Alector, Inc. | 38.91 Million USD | -515.7% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -20900.701% |
| Erasca, Inc. | 55.85 Million USD | -328.969% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1125.229% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -837.619% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -61026.729% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 78.867% |
| Histogen Inc. | 4.62 Million USD | -5084.293% |
| Fortress Biotech, Inc. | 88.59 Million USD | -170.474% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -2332.176% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -279.34% |
| Galecto, Inc. | 249 Thousand USD | -96132.129% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 62.842% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -72.35% |
| Molecular Templates, Inc. | 12.23 Million USD | -1859.264% |
| PDS Biotechnology Corporation | 23.85 Million USD | -904.62% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -5555.369% |
| Amarin Corporation plc | 8.73 Million USD | -2642.566% |
| TG Therapeutics, Inc. | 110.79 Million USD | -116.271% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -4339.837% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -9326.357% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1170.981% |
| Onconetix, Inc. | 9.88 Million USD | -2323.867% |
| MacroGenics, Inc. | 33.97 Million USD | -605.36% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -16786.399% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Adagene Inc. | 22.3 Million USD | -974.189% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -14.027% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -2087.293% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1080.791% |
| SciSparc Ltd. | 76 Thousand USD | -315186.842% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -192.157% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -72732.219% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -847.182% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -16.367% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -348.169% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 91.068% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -3029.236% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -380246.032% |
| 2seventy bio, Inc. | 256.67 Million USD | 6.645% |
| Clene Inc. | 32.16 Million USD | -645.058% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -10816.538% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -117411.071% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -2647.598% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Absci Corporation | 15.95 Million USD | -1401.648% |
| XBiotech Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1293.371% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -791.403% |
| Entera Bio Ltd. | 390 Thousand USD | -61340.513% |
| Trevena, Inc. | 35.23 Million USD | -580.095% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -849.546% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -771.814% |
| INmune Bio, Inc. | 10.43 Million USD | -2195.851% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -49691.271% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -3588.701% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -584334.146% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -787.803% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -47737.206% |
| Jaguar Health, Inc. | 35.86 Million USD | -568.204% |
| Clearside Biomedical, Inc. | 43 Million USD | -457.238% |
| NexImmune, Inc. | 68.8 Thousand USD | -348136.423% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -51430.753% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -19473.02% |
| Kronos Bio, Inc. | 28.27 Million USD | -747.545% |
| Innoviva, Inc. | 449.07 Million USD | 46.642% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 50.167% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 91.135% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1085.113% |
| Verastem, Inc. | 41.55 Million USD | -476.601% |
| ProKidney Corp. | 4.41 Million USD | -5329.821% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -15309.518% |
| Imunon, Inc. | 1.62 Million USD | -14648.319% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -18917.302% |
| Statera Biopharma, Inc. | 16.26 Million USD | -1373.562% |
| ImmunityBio, Inc. | 883.67 Million USD | 72.884% |
| Korro Bio, Inc. | 33.2 Million USD | -621.589% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 40.803% |
| Kineta, Inc. | 1.31 Million USD | -18094.229% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -6636.52% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -4169.626% |
| GT Biopharma, Inc. | 58 Thousand USD | -413034.483% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1558.945% |
| Celularity Inc. | 65.41 Million USD | -266.293% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -363.227% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cibus, Inc. | 24.62 Million USD | -873.226% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -237.604% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -117.128% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -62463.446% |
| Kodiak Sciences Inc. | 181.63 Million USD | -31.925% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -130.189% |
| Annexon, Inc. | 31.35 Million USD | -664.21% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -219.337% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -10131.341% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -3364.19% |
| Moderna, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1630.094% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 83.515% |
| Vor Biopharma Inc. | 35.66 Million USD | -571.952% |
| Eyenovia, Inc. | 16.1 Million USD | -1387.594% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -59804.5% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -114.923% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -420.467% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -646.055% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -24226.701% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -318.876% |
| Immunocore Holdings plc | 84.03 Million USD | -185.151% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -515.668% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -233.697% |
| Alkermes plc | 290.73 Million USD | 17.581% |
| Arcellx, Inc. | 97.62 Million USD | -145.447% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -9676.352% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -423.492% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -368543.077% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -7624.629% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -18901.799% |
| Moolec Science SA | 2.64 Million USD | -8958.292% |
| Biomea Fusion, Inc. | 10.29 Million USD | -2227.292% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 85.89 Million USD | -178.953% |
| Mereo BioPharma Group plc | 5.95 Million USD | -3925.84% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -426.517% |
| Royalty Pharma plc | 6.13 Billion USD | 96.094% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -9875.77% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -14282.833% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -207804.281% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -608.3% |
| Humacyte, Inc. | 58.1 Million USD | -312.381% |
| Structure Therapeutics Inc. | 5.45 Million USD | -4294.241% |
| NLS Pharmaceutics AG | 1.63 Million USD | -14566.784% |
| Genelux Corporation | 2.51 Million USD | -9412.426% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -298199.472% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1487.4% |
| Notable Labs, Ltd. | 2.04 Million USD | -11594.388% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -79583.021% |
| Mustang Bio, Inc. | 2.49 Million USD | -9492.394% |
| Immunovant, Inc. | 138 Thousand USD | -173536.232% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -14584.95% |
| Vericel Corporation | 88.14 Million USD | -171.851% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 84.017% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 29.22 Million USD | -719.936% |
| Orgenesis Inc. | 22.62 Million USD | -959.272% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -5098.915% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -117938.424% |
| GH Research PLC | 343 Thousand USD | -69759.475% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1059.76% |
| PepGen Inc. | 20.1 Million USD | -1091.892% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -41645.296% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -237145.545% |
| Belite Bio, Inc | 886 Thousand USD | -26944.921% |
| Pharming Group N.V. | 171.54 Million USD | -39.682% |
| XOMA Corporation | 124.45 Million USD | -92.542% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -24526.721% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 83.43 Million USD | -187.195% |
| Replimune Group, Inc. | 75.86 Million USD | -215.831% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1023.332% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -2448.043% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Turnstone Biologics Corp. | 3.21 Million USD | -7355.445% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1323.755% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -9813.86% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -18901.799% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -211951.327% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -23118.798% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -7485.248% |
| scPharmaceuticals Inc. | 40.26 Million USD | -495.043% |
| HilleVax, Inc. | 51.19 Million USD | -368.068% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -346.15% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2538.674% |
| Immunic, Inc. | 1.33 Million USD | -17862.369% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Aptorum Group Limited | 3.36 Million USD | -7026.404% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -59358.561% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2538.674% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -11115.714% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1332.18% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -11045.023% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 46.16% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -82628.738% |
| bluebird bio, Inc. | 330.32 Million USD | 27.46% |
| DBV Technologies S.A. | 14.38 Million USD | -1566.212% |
| Compugen Ltd. | 1.35 Million USD | -17636.343% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Peak Bio, Inc. | 10.72 Million USD | -2134.866% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -9477.058% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -3759.826% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -14103.794% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -460.3% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -5059.733% |
| Benitec Biopharma Inc. | 284 Thousand USD | -84272.535% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -183.387% |
| Adicet Bio, Inc. | 20.92 Million USD | -1045.183% |
| Prime Medicine, Inc. | 13.63 Million USD | -1657.632% |
| Aditxt, Inc. | 18.21 Million USD | -1215.283% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -104.464% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1465.824% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -29540.946% |
| PolyPid Ltd. | 11.77 Million USD | -1934.281% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -161.998% |
| Invivyd, Inc. | 2.16 Million USD | -10967.806% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -6800023.733% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -295.546% |
| CorMedix Inc. | 667.63 Thousand USD | -35790.73% |
| Instil Bio, Inc. | 86.05 Million USD | -178.451% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -372.88% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -24.031% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -695.386% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -4222.894% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1704.896% |
| AbCellera Biologics Inc. | 77.38 Million USD | -209.664% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -187.35% |
| Surrozen, Inc. | 3.37 Million USD | -6991.388% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -876.359% |
| Verona Pharma plc | 51.32 Million USD | -366.828% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -39637.645% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -92.402% |
| Evaxion Biotech A/S | 10.86 Million USD | -2104.463% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -219.887% |
| Shattuck Labs, Inc. | 4.2 Million USD | -5602.475% |
| AlloVir, Inc. | 27.42 Million USD | -773.594% |
| BioVie Inc. | 6.11 Million USD | -3820.806% |
| Codexis, Inc. | 22.36 Million USD | -971.445% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -26347.903% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -146037.942% |
| Agenus Inc. | 350.24 Million USD | 31.586% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -106729.247% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -102095.154% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1038.436% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1132.286% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Celcuity Inc. | 37.44 Million USD | -539.898% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -11050.209% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -741.149% |
| IN8bio, Inc. | 4.89 Million USD | -4797.159% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -17808.67% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -125.918% |
| Liquidia Corporation | 3.5 Million USD | -6740.365% |
| Quantum-Si incorporated | 15.3 Million USD | -1465.824% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -293261.9% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -2097.725% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -14395.947% |
| United Therapeutics Corporation | 700 Million USD | 65.769% |
| Solid Biosciences Inc. | 26.26 Million USD | -812.309% |
| Immuneering Corporation | 4.46 Million USD | -5269.039% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1704.896% |
| uniQure N.V. | 138.4 Million USD | -73.123% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1991.455% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -180.508% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -50345.895% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1703.538% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -113738.728% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1530.609% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -87351.825% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -695.096% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -24226.701% |
| Immunome, Inc. | 1.65 Million USD | -14422.303% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -13726.774% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -2350.583% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -693.194% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -66092.818% |
| Altimmune, Inc. | 671 Thousand USD | -35610.581% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -362.806% |
| Rallybio Corporation | 392 Thousand USD | -61027.041% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -5631.117% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -40860.342% |
| Moolec Science SA | 2.64 Million USD | -8958.292% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -57639.277% |
| NeurAxis, Inc. | 224.26 Thousand USD | -106748.301% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 60.781% |
| Lumos Pharma, Inc. | 6.58 Million USD | -3538.846% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -2350.583% |
| 180 Life Sciences Corp. | 1.32 Million USD | -18051.93% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1102.841% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1302.906% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -15309.518% |
| Nutriband Inc. | 241.28 Thousand USD | -99209.116% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -28909.443% |
| argenx SE | 20 Million USD | -1098.09% |
| Neurogene Inc. | 16.25 Million USD | -1374.119% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 22.238% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -739.557% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 17.81 Million USD | -1245.111% |
| Design Therapeutics, Inc. | 3.05 Million USD | -7756.328% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -91357.252% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1584.13% |
| Achilles Therapeutics plc | 4.61 Million USD | -5092.156% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -168645.07% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -2246.206% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 35.883% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -696.1% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -6379.899% |
| Palisade Bio, Inc. | 369 Thousand USD | -64837.127% |
| Beam Therapeutics Inc. | 173.17 Million USD | -38.369% |
| AEON Biopharma, Inc. | 278 Thousand USD | -86093.525% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -71427.761% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -224070.417% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -215.86% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -292.129% |
| Athira Pharma, Inc. | 1.58 Million USD | -15017.855% |
| Vaccinex, Inc. | 247 Thousand USD | -96911.336% |
| HCW Biologics Inc. | 6.45 Million USD | -3613.985% |
| XOMA Corporation | 124.45 Million USD | -92.542% |
| Nektar Therapeutics | 230.4 Million USD | -4.0% |
| Arvinas, Inc. | 3.4 Million USD | -6947.588% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -14584.95% |
| Merus N.V. | 12.16 Million USD | -1870.219% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -86.578% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1634.603% |
| Rezolute, Inc. | 2.22 Million USD | -10654.847% |
| Clene Inc. | 32.16 Million USD | -645.058% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -136783.115% |
| BeyondSpring Inc. | 3.99 Million USD | -5897.947% |
| Synlogic, Inc. | 17.27 Million USD | -1287.08% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -18332.154% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -684522.857% |
| Peak Bio, Inc. | 10.72 Million USD | -2134.866% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -361.487% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2860.44% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -35.365% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -3295.465% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -175323.518% |
| MannKind Corporation | 382.37 Million USD | 37.335% |
| Ikena Oncology, Inc. | 10.73 Million USD | -2131.496% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -58486.308% |
| Gossamer Bio, Inc. | 212.46 Million USD | -12.781% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -137611.494% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2515.631% |
| Legend Biotech Corporation | 328.67 Million USD | 27.095% |
| Mural Oncology plc | 15 Million USD | -1496.495% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -405.246% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -11304.95% |
| Champions Oncology, Inc. | 7.43 Million USD | -3125.007% |
| REGENXBIO Inc. | 89.29 Million USD | -168.359% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -27935.432% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -43231.971% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -4325.896% |
| Vaxart, Inc. | 26.51 Million USD | -803.741% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1430.386% |
| Cellectis S.A. | 92.85 Million USD | -158.062% |
| Longeveron Inc. | 2.04 Million USD | -11640.225% |
| Repare Therapeutics Inc. | 3.41 Million USD | -6926.921% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 82.845% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -414.29% |
| Revolution Medicines, Inc. | 87.94 Million USD | -172.467% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -138407.514% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -5961.675% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -75489.274% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -136824.571% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 70.359% |
| Denali Therapeutics Inc. | 52.24 Million USD | -358.678% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1563.383% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -17339.447% |
| Cingulate Inc. | 3.13 Million USD | -7543.076% |
| Passage Bio, Inc. | 26.29 Million USD | -811.303% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -3495.169% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -58629.902% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -26702.908% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -172.467% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1065.401% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -18917.302% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -9675.854% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -7572.687% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -29445.993% |
| OmniAb, Inc. | 25.56 Million USD | -837.436% |
| Anew Medical, Inc. | 1.6 Million USD | -14829.47% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -709.989% |
| Lipocine Inc. | 17.16 Thousand USD | -1395787.219% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1958.928% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -591.978% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3956.469% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -319.11% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -117938.424% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -4539.264% |
| Ocugen, Inc. | 6.94 Million USD | -3352.211% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1595.93% |
| Q32 Bio Inc. | 1.31 Million USD | -18080.425% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -35557.44% |
| Alumis Inc. Common Stock | 32.58 Million USD | -635.476% |
| Equillium, Inc. | 824 Thousand USD | -28979.854% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -2539.255% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -79558.65% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -57.334% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -368.571% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -30816.537% |
| Dominari Holdings Inc. | 3.02 Million USD | -7813.408% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -253498.908% |
| vTv Therapeutics Inc. | 529 Thousand USD | -45196.408% |
| Bio-Techne Corporation | 419.53 Million USD | 42.885% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -232.821% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -23.791% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1318.865% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -952.711% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -3855.398% |
| Nkarta, Inc. | 88.33 Million USD | -171.248% |
| BioCardia, Inc. | 1.31 Million USD | -18121.901% |
| Iterum Therapeutics plc | 19.5 Million USD | -1128.243% |